HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P K Ahring Selected Research

bretazenil

12/2008Comparison of the novel subtype-selective GABAA receptor-positive allosteric modulator NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with diazepam, zolpidem, bretazenil, and gaboxadol in rat models of inflammatory and neuropathic pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P K Ahring Research Topics

Disease

3Pain (Aches)
02/2015 - 07/2005
2Hyperalgesia
02/2015 - 12/2008
1Ataxia (Dyssynergia)
12/2008
1Neuralgia (Stump Neuralgia)
12/2008
1Hypersensitivity (Allergy)
12/2008
1Epilepsy (Aura)
07/2005
1Mania (Manias)
07/2005

Drug/Important Bio-Agent (IBA)

2Pharmaceutical PreparationsIBA
12/2008 - 07/2005
2BenzodiazepinesIBA
12/2008 - 12/2008
23'- (5- (1- hydroxy- 1- methylethyl)benzoimidazol- 1- yl)biphenyl- 2- carbonitrileIBA
12/2008 - 12/2008
1CarrageenanIBA
02/2015
1GABA-A Receptors (GABA(A) Receptor)IBA
12/2008
1gaboxadol (THIP)IBA
12/2008
1bretazenilIBA
12/2008
1Zolpidem (Ambien)FDA LinkGeneric
12/2008
1Ethanol (Ethyl Alcohol)IBA
12/2008
1Diazepam (Valium)FDA LinkGeneric
12/2008
1diphenyl (biphenyl)IBA
12/2008

Therapy/Procedure

1Analgesia
02/2015